Multicenter Phase 2 Study of Oral azacitidine (CC-486) plus CHOP as initial treatment for peripheral T-cell lymphomaJia Ruan, Peter W. Martin, Zhengming Chen et al.|Blood|2023Cited by 47
A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilitiesDanilo Fiore, Inna Khodos, Luca Vincenzo Cappelli et al.|Cell Reports Medicine|2025Cited by 8